Key result
Clopidogrel monotherapy serves as a consistent long-term secondary prevention strategy following PCI.
Answers are grounded in this paper and cite their sources.
May support clopidogrel monotherapy post-PCI; leaves open confirmation in larger trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Woong Choi (2026) studied this question. Clopidogrel monotherapy serves as a consistent strategy for long-term secondary prevention following percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: